On the public citation graph

Higher Buprenorphine Dose Associated with Increased Treatment Retention at Mobile Buprenorphine Clinic: A Retrospective Cohort Study

0 signed · 25 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamapsychiatry.2021.0976openalex-extracted
The impact of opioid agonist treatment delivered in different settings on all-cause mortality and specific causes of death:A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.drugalcdep.2014.07.035openalex-extracted
Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
inferredcites →https://doi.org/10.1016/j.drugalcdep.2020.108317openalex-extracted
Adherence to buprenorphine: An analysis of prescription drug monitoring program data
inferredcites →https://doi.org/10.1016/j.drugalcdep.2021.108710openalex-extracted
Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017
inferredcites →https://doi.org/10.1016/j.jsat.2014.12.011openalex-extracted
Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes
inferredcites →https://doi.org/10.1016/j.jsat.2015.09.004openalex-extracted
The Effect of a Payer-Mandated Decrease in Buprenorphine Dose on Aberrant Drug Tests and Treatment Retention Among Patients with Opioid Dependence
inferredcites →https://doi.org/10.1016/j.jsat.2019.05.002openalex-extracted
Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap
inferredcites →https://doi.org/10.1056/nejm200011023431802openalex-extracted
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
inferredcites →https://doi.org/10.1056/nejmoa022164openalex-extracted
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone
inferredcites →https://doi.org/10.1056/nejmp2017363openalex-extracted
A Good Place to Start — Low-Threshold Buprenorphine Initiation
inferredcites →https://doi.org/10.1080/10550887.2011.642758openalex-extracted
Effect of Buprenorphine Dose on Treatment Outcome
inferredcites →https://doi.org/10.1080/17512433.2019.1635454openalex-extracted
Buprenorphine treatment for opioid use disorder: recent progress
inferredcites →https://doi.org/10.1097/adm.0000000000000555openalex-extracted
Defining Low-threshold Buprenorphine Treatment
inferredcites →https://doi.org/10.1097/adm.0000000000000774openalex-extracted
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic
inferredcites →https://doi.org/10.1111/1475-6773.12201openalex-extracted
The Impact of Prior Authorization on Buprenorphine Dose, Relapse Rates, and Cost for Massachusetts Medicaid Beneficiaries with Opioid Dependence
inferredcites →https://doi.org/10.1111/add.12315openalex-extracted
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone
inferredcites →https://doi.org/10.1111/ajad.12288openalex-extracted
Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories
inferredcites →https://doi.org/10.1136/bmj.j1550openalex-extracted
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
inferredcites →https://doi.org/10.1176/ajp.2007.164.5.797openalex-extracted
A Stepped Care Strategy Using Buprenorphine and Methadone Versus Conventional Methadone Maintenance in Heroin Dependence: A Randomized Controlled Trial
inferredcites →https://doi.org/10.1377/hlthaff.2019.01622openalex-extracted
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others
inferredcites →https://doi.org/10.15585/mmwr.mm7006a4openalex-extracted
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019
inferredcites →https://doi.org/10.15585/mmwr.mm7050e3openalex-extracted
Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020
inferredcites →https://doi.org/10.17226/25310openalex-extracted
Medications for Opioid Use Disorder Save Lives
inferredcites →https://doi.org/10.7326/m17-3107openalex-extracted
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109891openalex-snapshot
Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015–2022
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.